A renewed Strategic Plan
Uniting stakeholders to share knowledge, foster collaboration, enable solutions and to support the most critical issues, risks and challenges faced by the field
玲珑加速器模式
Mobilizing new funding to support and grow the field of HIV vaccine research and development
玲珑加速器换节点
Promoting more efficient, faster ways for researchers to share successes and failures and avoid duplication of efforts
bluelayer加速器官网下载-旋风加速度器
With over 600 virtual sessions and events, AIDS 2024: Virtual will enable delegates to access and engage with the latest HIV science, advocacy and knowledge traditionally presented at the conference, while offering a range of new features made possible by the new virtual format. Biomedical prevention interventions have saved lives and helped prevent new HIV infections. However, declines in incidence remain far from UNAIDS targets. A safe and globally effective HIV vaccine remains a necessity for a durable control and end to the epidemic. Download the HIV vaccine, and vaccine research roadmap.
Read more
bluelayer加速器官网下载-旋风加速度器
This scientific and technical workshop aims to continue from the first HIV Prevention Efficacy Trial Designs of the Future symposium, held in November 2018 in Seattle by the Fred Hutch and the NIAID. Participants will reflect on more recent advances and challenges within the HIV prevention field and on the rationale and lessons learned for current HIV prevention designs.
Read more
bluelayer加速器官网下载-旋风加速度器
C. Bickel, Science Translational Medicine; National Institute of Allergy and Infectious Diseasesbluelayer加速器官网下载-旋风加速度器
bluelayer加速器官网下载-旋风加速度器
2nd Infant Trials Workshop
Knowns and Unknowns of Assaying ADCC against HIV
bluelayer加速器官网下载-旋风加速度器
Sign up to receive the latest news of the Vaccine Enterprise and occasional information related to IAS activities related to vaccine research and development (Please read our Privacy Policy)
Contact Us
